<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2340-9894</journal-id>
<journal-title><![CDATA[Ars Pharmaceutica (Internet)]]></journal-title>
<abbrev-journal-title><![CDATA[Ars Pharm]]></abbrev-journal-title>
<issn>2340-9894</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Granada]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2340-98942020000200006</article-id>
<article-id pub-id-type="doi">10.30827/ars.v61i2.115337</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Impacto financiero de la terapia con antibióticos en la resistencia a múltiples fármacos bacterianos en un hospital de emergencia en Pernambuco, Brasil]]></article-title>
<article-title xml:lang="en"><![CDATA[Financial impact of antibiotic therapy face to bacterial multiresistance in emergency hospital in Pernambuco, Brazil]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[Gabriel Romero Melo do Rêgo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Melo]]></surname>
<given-names><![CDATA[Cícero Erison dos Santos Espíndola]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[Maria Izabelle Santos de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Germinio]]></surname>
<given-names><![CDATA[Josefa Elaine Silva]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[Rosiel José dos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[Sibele Ribeiro de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Universitário Tabosa de Almeida (Asces-Unita)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade Federal de Pernambuco Departamento de Tecnologia e Geociências ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<volume>61</volume>
<numero>2</numero>
<fpage>121</fpage>
<lpage>126</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2340-98942020000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2340-98942020000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2340-98942020000200006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: El objetivo de este artículo fue analizar los costos financieros de la terapia con antibióticos contra la resistencia bacteriana en un hospital público de alta complejidad en Agreste Pernambucano.  Método: Se realizó un estudio descriptivo, retrospectivo y transversal a partir de los datos recopilados de los registros de la Comisión de Control de Infecciones Hospitalarias (CCIH), la Farmacia y el Centro de Suministros Farmacéuticos (CAF) del hospital investigado. Esto se obtuvo a través de un instrumento de recolección estructurado, con datos correspondientes al período de enero a diciembre de 2016.  Resultados: Las principales muestras clínicas con presencia de resistencia a múltiples fármacos bacterianos fueron sangre, orina y secreción traqueal, con mayor prevalencia de las siguientes bacterias: Staphylococcus aureus(23,08%), Staphylococcuscoagulasa negativo (26,15%), Citrobactersp. (19,23%), Enterobactersp. (10,77%) y Pseudomonassp. (7,69%). En vista de la resistencia a múltiples fármacos presentada, los antibióticos más utilizados para el tratamiento fueron: vancomicina (21,7%), piperacilina con tazobactam (24,55%), ampicilina con sulbactam (10.4%), cefepima (18,43%) y meropenem (58,5%). La presencia de bacterias resistentes fue la causa del aumento de los costos en el tratamiento de los pacientes. Los valores en este estudio con terapia con antibióticos generaron un costo de R$ 83.298,83 en 2016, con el 49% de las muertes hospitalarias.  Conclusión: La prevención, a través de políticas relacionadas con el control racional y el uso de antimicrobianos, es fundamental en la lucha contra las infecciones nosocomiales por bacterias multirresistentes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: The objective of this article was to analyze the financial costs of antibiotic therapy against bacterial resistance in a public hospital of high complexity located in the Agreste region of Pernambuco.  Method: It was performed a descriptive, retrospective and cross-sectional study based on data collected from Hospital Infection Control Commission (CCIH) and the Pharmaceutical Supply Center (CAF) of the investigated hospital. It was obtained by a structured instrument of data collection and the period analysed was from January to December 2016.  Results: The main clinical samples with presence of bacterial multiresistance were blood, urine and tracheal secretion, with a higher prevalence of the following bacteria: Staphylococcus aureus(23,08%), Coagulase-negative Staphylococcus(26,15%), Citrobactersp. (19,23%), Enterobactersp. (10,77%) and Pseudomonassp (7,69%). Faced to the multiresistance presented, the most common antibiotics used in the treatment were: vancomycin (21,7%), piperacillin-tazobactam (24,55%), ampicillin-sulbactam (10,4%), cefepime (18,43%) and meropenem (58,5%). The presence of resistant bacteria was a cause of increased costs in the treatment of patients. According to this study, the antibiotic therapy listed above generated a cost of R$ 83.298,83 and 49% of hospital death in 2016.  Conclusion: The prevention, through of policies related to the control and rational use of antimicrobials, is fundamental in the fight against hospital infections caused by multiresistant bacteria.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Bacterias]]></kwd>
<kwd lng="es"><![CDATA[Resistencia a los medicamentos microbianos]]></kwd>
<kwd lng="es"><![CDATA[Costos hospitalarios]]></kwd>
<kwd lng="en"><![CDATA[Bacteria]]></kwd>
<kwd lng="en"><![CDATA[Drug Resistance Microbial]]></kwd>
<kwd lng="en"><![CDATA[Hospital Costs]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Georreferenciamento de bactérias multirresistentes do Hospital de Clínicas de Porto Alegre]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patzer]]></surname>
<given-names><![CDATA[CCW]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Lewoy]]></surname>
<given-names><![CDATA[AMB]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
</person-group>
<source><![CDATA[J Infect Control]]></source>
<year>2015</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>12-6</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="">
<article-title xml:lang=""><![CDATA[O Uso De Antimicrobianos No Âmbito Hospitalar E As Atribuições Do Farmacêutico Na Comissão De Controle De Infecção Hospitalar (CCIH)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vasconcelos]]></surname>
<given-names><![CDATA[DV]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[LLN]]></given-names>
</name>
</person-group>
<source><![CDATA[]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[O Papel Do Farmacêutico Frente À Resistência Bacteriana Ocasionada Pelo Uso]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franco]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Cabral]]></surname>
<given-names><![CDATA[FRF]]></given-names>
</name>
<name>
<surname><![CDATA[Menezes]]></surname>
<given-names><![CDATA[CDA]]></given-names>
</name>
</person-group>
<source><![CDATA[Semana Acadêmica]]></source>
<year>2015</year>
<volume>1</volume>
<numero>72</numero>
<issue>72</issue>
<page-range>1-17</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Uso irracional e resistência a antimicrobianos em hospitais]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vieira]]></surname>
<given-names><![CDATA[P Noemi]]></given-names>
</name>
<name>
<surname><![CDATA[Vieira]]></surname>
<given-names><![CDATA[SL Vicentino]]></given-names>
</name>
</person-group>
<source><![CDATA[Arq Ciênc Saúde]]></source>
<year>2017</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>209-12</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Antibióticos e resistência bacteriana, velhas questões, novos desafios]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Monteiro]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Menezes]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
</person-group>
<source><![CDATA[Cadernos Otorrinolaringologia, clínica, investigação e inovação]]></source>
<year>2010</year>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Análisis epidemiológico: profilaxis y multirresistencia en cirugía]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Solís-Téllez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Mondragón-Pinzón]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Marino]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Espinoza-López]]></surname>
<given-names><![CDATA[FR]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez-Sosa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rubio-Suarez]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<source><![CDATA[Revista de Gastroenterología de México]]></source>
<year>2017</year>
<volume>82</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>115-22</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Fatores associados a infecções hospitalares causadas por microorganismos multirresistentes num hospital de ensino]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferraz]]></surname>
<given-names><![CDATA[CCB]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[FB]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[Leite]]></surname>
<given-names><![CDATA[LRC]]></given-names>
</name>
<name>
<surname><![CDATA[Hildebrand]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<source><![CDATA[Perspectivas Experimentais e Clínicas, Inovações Biomédicas e Educação em Saúde, PECIBES]]></source>
<year>2016</year>
<volume>2</volume>
<page-range>52-7</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Impacto financeiro das infecções nosocomiais em unidades de terapia intensiva em hospital filantrópico de Minas Gerais]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nangino]]></surname>
<given-names><![CDATA[GO]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Correia]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[ATB]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Bras Intensiva]]></source>
<year>2012</year>
<volume>24</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>357-61</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Custo e caracterização de infecção hospitalar em idosos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Izaias]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Dellaroza]]></surname>
<given-names><![CDATA[MSG]]></given-names>
</name>
<name>
<surname><![CDATA[Rossaneis]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Belei]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<source><![CDATA[Ciência &amp; Saúde Coletiva]]></source>
<year>2014</year>
<volume>19</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>3395-402</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Caracterização das infecções relacionadas à assistência à saúde em unidade de terapia intensiva]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[PO]]></given-names>
</name>
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[ETA]]></given-names>
</name>
<name>
<surname><![CDATA[Valença]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Aracele-Cavalcanti]]></surname>
<given-names><![CDATA[ATA]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev enferm UFPE on line]]></source>
<year>2014</year>
<volume>8</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1577-85</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Quais os fatores de risco e agentes responsáveis por infecções bacterianas em UTI?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
<name>
<surname><![CDATA[Brixner]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Renner]]></surname>
<given-names><![CDATA[JDP]]></given-names>
</name>
</person-group>
<source><![CDATA[O Mundo da Sáude]]></source>
<year>2018</year>
<volume>42</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>61-76</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Factores clínicos asociados a multirresistencia bacteriana en un hospital de cuarto nível]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quintero]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Echeverri-Toro]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ospina]]></surname>
<given-names><![CDATA[SO]]></given-names>
</name>
</person-group>
<source><![CDATA[Infectio]]></source>
<year>2015</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>161-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Impacto das infecções relacionadas à assistência à saúde em pacientes acometidos por trauma]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[VF]]></given-names>
</name>
<name>
<surname><![CDATA[Ottunes]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Dessunti]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Pieri]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[EAP]]></given-names>
</name>
</person-group>
<source><![CDATA[Semina: Ciências Biológicas e da Saúde]]></source>
<year>2015</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>89-98</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Perfil de utilização de medicamentos anti-infecciosos sistêmicos em um hospital oncológico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Slomp]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Carneiro]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Bernardi]]></surname>
<given-names><![CDATA[EAT]]></given-names>
</name>
</person-group>
<source><![CDATA[Revista Espaço para a Saúde]]></source>
<year>2014</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>42-52</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ventilator-associated pneumonia the influence of bacterial resistance, prescription errors, and de-escalation of antimicrobial therapy on mortality rates]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Souza-Oliveira]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Cunha]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Passos]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Lopes]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Röder]]></surname>
<given-names><![CDATA[DV]]></given-names>
</name>
</person-group>
<source><![CDATA[Braz J Infect Dis]]></source>
<year>2016</year>
<numero>5</numero>
<issue>5</issue>
<page-range>437-43</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluación del consumo de antimicrobianos en 15 hospitales chilenos. Resultados de un trabajo colaborativo, 2013]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rosales]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cabello]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bavestrello]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Labarca]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Chilena Infectol]]></source>
<year>2016</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>307-12</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Perspectivas da química medicinal para o século xxi: desafios e oportunidades]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Kümmerle]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Guido]]></surname>
<given-names><![CDATA[RVC]]></given-names>
</name>
</person-group>
<source><![CDATA[Quim Nova]]></source>
<year>2018</year>
<volume>41</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>476-83</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[VB]]></given-names>
</name>
</person-group>
<source><![CDATA[Detecção de resistência aos carbapenêmicos e avaliação de produção de Klebsiella pneumoniae Carbapenemases (KPC) em isolados clínicos da família Enterobacteriaceae]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Porto Alegre ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="book">
<collab>Centro Europeu de Prevenção e Controlo das Doenças</collab>
<source><![CDATA[Antibióticos de última linha estão a falhar: opções para lidar com esta ameaça urgente aos doentes e sistemas de saúde]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Estocolmo ]]></publisher-loc>
<publisher-name><![CDATA[ECDC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prescrições de antimicrobianos de uso restrito de pacientes internados em um hospital de ensino]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[CDS]]></given-names>
</name>
<name>
<surname><![CDATA[Lemos]]></surname>
<given-names><![CDATA[LB Brasileiro]]></given-names>
</name>
<name>
<surname><![CDATA[Jesus]]></surname>
<given-names><![CDATA[IS]]></given-names>
</name>
<name>
<surname><![CDATA[Silveira Lemos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Bras Farm Hosp Serv Saúde]]></source>
<year>2016</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-12</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Interações medicamentosas potenciais em prescrições, contendo antimicrobianos de uso restrito, de pacientes internados em um hospital no interior da Bahia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piedade]]></surname>
<given-names><![CDATA[DV]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[LAF]]></given-names>
</name>
<name>
<surname><![CDATA[Lemos]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Valasques Júnior]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Lemos]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
</person-group>
<source><![CDATA[Medicina (Ribeirão Preto)]]></source>
<year>2015</year>
<volume>48</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>295-307</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Heath Care-Associated Infections. A Meta-analysis of Costs and Financial Impact on the US Heath Care System]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zimlichman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Henderson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Tamir]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Franz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Yamin]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA Intern Med]]></source>
<year>2013</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
